A new study is recruiting patients with malignant pleural mesothelioma to study a combination therapy of targeted radiation and chemotherapy.

The standard treatment for malignant pleural mesothelioma patients has often been removal of a patient's lung, a risky and debilitating surgery. Researchers hope combination therapy will give patients additional treatment options instead of drastic surgery.

Read more here